In:
International Journal of Hematology-Oncology and Stem Cell Research, Knowledge E DMCC, ( 2020-04-17)
Abstract:
Acute Lymphoblastic Leukemia is a very aggressive malignant disorder of lymphoid cells in adults, with recurrence (30 to 60% of the cases) after the initial treatment. Until this moment, there is no gold standard therapy for the treatment of adult patients with acute relapsed/refractory lymphoblastic leukemia. In this case report, we describe two cases of relapsed leukemia: one of lymphocytic leukemia B and one of trilineage leukemia, which presented a satisfactory response to treatment with Bortezomib associated with Vincristine, Dexamethasone, and Bendamustine.
Type of Medium:
Online Resource
ISSN:
2008-2207
DOI:
10.18502/ijhoscr.v14i2.2676
Language:
Unknown
Publisher:
Knowledge E DMCC
Publication Date:
2020
detail.hit.zdb_id:
2652853-8
